1273 related articles for article (PubMed ID: 29210030)
1. Pharmacologic prevention of variceal bleeding and rebleeding.
Baiges A; Hernández-Gea V; Bosch J
Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
[TBL] [Abstract][Full Text] [Related]
2. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
3. Complications of cirrhosis. I. Portal hypertension.
Bosch J; García-Pagán JC
J Hepatol; 2000; 32(1 Suppl):141-56. PubMed ID: 10728801
[TBL] [Abstract][Full Text] [Related]
4. 5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.
Vukotic R; Di Donato R; Roncarati G; Simoni P; Renzulli M; Gitto S; Schepis F; Villa E; Berzigotti A; Bosch J; Andreone P
J Hepatol; 2023 Oct; 79(4):977-988. PubMed ID: 37482222
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of variceal haemorrhage in 2017.
Brunner F; Berzigotti A; Bosch J
Liver Int; 2017 Jan; 37 Suppl 1():104-115. PubMed ID: 28052623
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
Vijayaraghavan R; Jindal A; Arora V; Choudhary A; Kumar G; Sarin SK
Am J Gastroenterol; 2020 May; 115(5):729-737. PubMed ID: 32079861
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial.
Shah HA; Azam Z; Rauf J; Abid S; Hamid S; Jafri W; Khalid A; Ismail FW; Parkash O; Subhan A; Munir SM
J Hepatol; 2014 Apr; 60(4):757-64. PubMed ID: 24291366
[TBL] [Abstract][Full Text] [Related]
9. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
Bosch J; Iwakiri Y
Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
11. [The effect of propranolol on portal hypertension].
Kovacević N; Tomić D; Perisić-Savić M; Grbić R
Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding.
Abd ElRahim AY; Fouad R; Khairy M; Elsharkawy A; Fathalah W; Khatamish H; Khorshid O; Moussa M; Seyam M
Hepatol Int; 2018 Jan; 12(1):75-82. PubMed ID: 29185106
[TBL] [Abstract][Full Text] [Related]
13. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
14. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
Reiberger T; Ferlitsch A; Payer BA; Pinter M; Homoncik M; Peck-Radosavljevic M;
J Gastroenterol; 2012 May; 47(5):561-8. PubMed ID: 22170417
[TBL] [Abstract][Full Text] [Related]
15. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
Laleman W; Nevens F
Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
[TBL] [Abstract][Full Text] [Related]
16. Primary prophylaxis of variceal bleeding.
Simonetto DA; Shah VH; Kamath PS
Clin Liver Dis; 2014 May; 18(2):335-45. PubMed ID: 24679498
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension.
Turco L; Reiberger T; Vitale G; La Mura V
Liver Int; 2023 Jun; 43(6):1183-1194. PubMed ID: 36897563
[TBL] [Abstract][Full Text] [Related]
18. Beta blockers and cirrhosis, 2016.
Mandorfer M; Reiberger T
Dig Liver Dis; 2017 Jan; 49(1):3-10. PubMed ID: 27717792
[TBL] [Abstract][Full Text] [Related]
19. Preventing first variceal hemorrhage in cirrhosis.
Albillos A
J Clin Gastroenterol; 2007; 41 Suppl 3():S305-11. PubMed ID: 17975481
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]